(Q51838983)

English

Genetic immunization with GPI-anchored anthrax protective antigen raises combined CD1d- and MHC II-restricted antibody responses by natural killer T cell-mediated help.

scientific article published on 3 February 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/19195490

Genetic immunization with GPI-anchored anthrax protective antigen raises combined CD1d- and MHC II-restricted antibody responses by natural killer T cell-mediated help. (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/19195490

0 references

author name string

Shuchi Midha

1

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/19195490

Rakesh Bhatnagar

2

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/19195490

language of work or name

0 references

publication date

3 February 2009

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/19195490

number of pages

10

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/19195490

27

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/19195490

11

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/19195490

1700-1709

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/19195490

Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.042

7 January 2021

Identification of the cellular receptor for anthrax toxin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.042

7 January 2021

Anthrax toxin protective antigen is activated by a cell surface protease with the sequence specificity and catalytic properties of furin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.042

7 January 2021

Anthrax protective antigen: prepore-to-pore conversion

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.042

7 January 2021

Mechanism of membrane translocation by anthrax toxin: insertion and pore formation by protective antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.042

7 January 2021

Anthrax toxin triggers endocytosis of its receptor via a lipid raft-mediated clathrin-dependent process

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.042

7 January 2021

Manipulation of host signalling pathways by anthrax toxins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.042

7 January 2021

The lethal and edema factors of anthrax toxin bind only to oligomeric forms of the protective antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.042

7 January 2021

Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.042

7 January 2021

Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.042

7 January 2021

Susceptibility of mitogen-activated protein kinase kinase family members to proteolysis by anthrax lethal factor

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.042

7 January 2021

Macrophage apoptosis by anthrax lethal factor through p38 MAP kinase inhibition

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.042

7 January 2021

Anthrax toxins suppress T lymphocyte activation by disrupting antigen receptor signaling

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.042

7 January 2021

Analysis of adverse events after anthrax immunization in US Army medical personnel

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.042

7 January 2021

Enhancement of antibody responses to Bacillus anthracis protective antigen domain IV by use of calreticulin as a chimeric molecular adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.042

7 January 2021

PLGA-dendron nanoparticles enhance immunogenicity but not lethal antibody production of a DNA vaccine against anthrax in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.042

7 January 2021

Strong mucosal and systemic immunities induced by nasal immunization with anthrax protective antigen protein incorporated in liposome-protamine-DNA particles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.042

7 January 2021

Evaluation of the VP22 protein for enhancement of a DNA vaccine against anthrax

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.042

7 January 2021

A cationic lipid-formulated plasmid DNA vaccine confers sustained antibody-mediated protection against aerosolized anthrax spores

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.042

7 January 2021

Protection of mice against challenge with Bacillus anthracis STI spores after DNA vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.042

7 January 2021

Genetic immunization against anthrax

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.042

7 January 2021

Protection against anthrax lethal toxin challenge by genetic immunization with a plasmid encoding the lethal factor protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.042

7 January 2021

Protection against anthrax toxin by vaccination with a DNA plasmid encoding anthrax protective antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.042

7 January 2021

Differential sorting and fate of endocytosed GPI-anchored proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.042

7 January 2021

Requirements for glycosylphosphatidylinositol attachment are similar but not identical in mammalian cells and parasitic protozoa

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.042

7 January 2021

Functional regulation of tissue plasminogen activator on the surface of vascular smooth muscle cells by the type-II transmembrane protein p63 (CKAP4).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.042

7 January 2021

CD1d-restricted immunoglobulin G formation to GPI-anchored antigens mediated by NKT cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.042

7 January 2021

Differential antitumor immunity mediated by NKT cell subsets in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.042

7 January 2021

Expression and purification of the recombinant protective antigen of Bacillus anthracis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.042

7 January 2021

Breaking down the wall: fractionation of mycobacteria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.042

7 January 2021

In vitro and in vivo characterization of anthrax anti-protective antigen and anti-lethal factor monoclonal antibodies after passive transfer in a mouse lethal toxin challenge model to define correlates of immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.042

7 January 2021

The influence of CD1d in postselection NKT cell maturation and homeostasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.042

7 January 2021

Identification of the earliest B lineage stage in mouse bone marrow

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.042

7 January 2021

Enzyme-linked immunosorbent assay-IgG antibody avidity test for single sample serologic evaluation of measles vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.042

7 January 2021

The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.042

7 January 2021

In-vitro characterisation of the phagocytosis and fate of anthrax spores in macrophages and the effects of anti-PA antibody.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.042

7 January 2021

The detection of protective antigen (PA) associated with spores of Bacillus anthracis and the effects of anti-PA antibodies on spore germination and macrophage interactions.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.042

7 January 2021

Search for correlates of protective immunity conferred by anthrax vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.042

7 January 2021

Contribution of immunological memory to protective immunity conferred by a Bacillus anthracis protective antigen-based vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.042

7 January 2021

Immunological correlates for protection against intranasal challenge of Bacillus anthracis spores conferred by a protective antigen-based vaccine in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.042

7 January 2021

Natural ligand of mouse CD1d1: cellular glycosylphosphatidylinositol.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.042

7 January 2021

Antigen-specific interaction between T and B cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.042

7 January 2021

CD1d-restricted help to B cells by human invariant natural killer T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.042

7 January 2021

Microdomains of GPI-anchored proteins in living cells revealed by crosslinking

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.042

7 January 2021

Human CD1-restricted T cell recognition of lipids from pollens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.042

7 January 2021

DNA vaccine combinations expressing either tissue plasminogen activator signal sequence fusion proteins or ubiquitin-conjugated antigens induce sustained protective immunity in a mouse model of pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.042

7 January 2021

Identifiers

10.1016/J.VACCINE.2009.01.042

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/19195490

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/19195490

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51838983&oldid=1775319676"